Middle meningeal artery embolization (MMAE) is an effective modality for treating CSDH, significantly reducing the risk of hematoma recurrence and progression.
Zhang et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: